PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou… Mar 2, 2021
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and… Mar 1, 2021
Accessible Neuroimaging Could Change Future of Psychedelic Therapy; Cybin’s Newest Collaboration Feb 28, 2021
TAAT™ Prepares to Expand into Canada by Partnering with a British Columbia Life Sciences Firm to Develop and Distribute… Feb 26, 2021
